DPP4 and metabolic dysfunction-associated steatotic liver disease: The fasting serum DPP-4 enzymatic activity (sDPP-4) was measured in patients with NAFLD and in similarly obese patients with type 2 diabetes but without clinically evident liver disease (defined as T2D group) and also in healthy controls (CNTRL).